Formic Acid → HCID 86711148, compound
Reaction equation
[C:1]([CH:3]1[NH:8][CH2:7][CH2:6][N:5]([C:9]([O:11][C:12]([CH3:15])([CH3:14])[CH3:13])=[O:10])[CH2:4]1)#[N:2].[OH:16][CH2:17][CH2:18][O:19][CH2:20][CH:21]=O.C(O)=O.C([BH3-])#N.[Na+]>ClCCl.O>[C:1]([CH:3]1[N:8]([CH2:21][CH2:20][O:19][CH2:18][CH2:17][OH:16])[CH2:7][CH2:6][N:5]([C:9]([O:11][C:12]([CH3:15])([CH3:14])[CH3:13])=[O:10])[CH2:4]1)#[N:2]Participants
7
Procedure
A solution of tert-butyl 3-cyanopiperazine-1-carboxylate, prepared as described in the previous step, (10 g, 0.047 mol) and 2-(2-hydroxyethoxy)acetaldehyde (14.8 g) (see: Bodin, A., Contact Dermatitis, 2001, 44:207) in dichloromethane was treated with formic acid (12.7 g), and the reaction mixture was stirred at room temperature overnight. Sodium cyanoborohydride (7.2 g, 0.118 mol) was added in portions. The reaction mixture was stirred at room temperature for 3 hours followed by the addition of water and extraction with dichloromethane. The organic layer was washed with brine, dried over sodium sulfate, filtered, and concentrated. The crude product was purified by column chromatography to provide the product.
Workup
- stirringThe reaction mixture was stirred at room temperature for 3 hours
- washThe organic layer was washed with brine
- dry with materialdried over sodium sulfate
- filtrationfiltered
- concentrationconcentrated
- customThe crude product was purified by column chromatography
- customto provide the product
Sources & evidence
- ORD record
- ord-1e69c7802a6642d88f61509299098c04
- Source dataset
- uspto-grants-2016_04
- Patent number
- US09304126B2
Reaction notes
Loading…